This paper presents a power-efficient Ultra Low Voltage (ULV) Fully-Differential (FD) Digital-Based Operational Transconductance Amplifier for Biomedical signal processing (BioDIGOTA), which digitally processes biological analog signals using CMOS standard-cells. Post-layout simulations, including parasitic effects in 180nm CMOS technology, show that BioDIGOTA consumes only 144 nW at 300 mV of supply voltage while driving a 20pF capacitive load, with a power efficiency factor (PEF) lower than 1. The layout uses 0.03 mm2 of the total silicon area, excluding I/0 pads. The proposed BioDIGOTA proves that digital-based analog design can be adopted in biomedical signal amplifiers, lowering the total silicon area by 2.3X times compared to the current state of the art landscape while keeping reasonable power and system performance.
A 300mV-Supply, 144nW-Power, 0.03mm2-Area, 0.2-PEF Digital-Based Biomedical Signal Amplifier in 180nm CMOS / Pedro, Toledo; Klimach, Hamilton; Bampi, Sergio; Crovetti, PAOLO STEFANO. - STAMPA. - (2021). (Intervento presentato al convegno 2021 IEEE International Symposium on Medical Measurements and Applications (MeMeA) tenutosi a Lausanne, Switzerland nel 23-25 June 2021) [10.1109/MeMeA52024.2021.9478709].
A 300mV-Supply, 144nW-Power, 0.03mm2-Area, 0.2-PEF Digital-Based Biomedical Signal Amplifier in 180nm CMOS
Pedro Toledo;Paolo Crovetti
2021
Abstract
This paper presents a power-efficient Ultra Low Voltage (ULV) Fully-Differential (FD) Digital-Based Operational Transconductance Amplifier for Biomedical signal processing (BioDIGOTA), which digitally processes biological analog signals using CMOS standard-cells. Post-layout simulations, including parasitic effects in 180nm CMOS technology, show that BioDIGOTA consumes only 144 nW at 300 mV of supply voltage while driving a 20pF capacitive load, with a power efficiency factor (PEF) lower than 1. The layout uses 0.03 mm2 of the total silicon area, excluding I/0 pads. The proposed BioDIGOTA proves that digital-based analog design can be adopted in biomedical signal amplifiers, lowering the total silicon area by 2.3X times compared to the current state of the art landscape while keeping reasonable power and system performance.| File | Dimensione | Formato | |
|---|---|---|---|
| MEMEA_2021__invited_final.pdf accesso aperto 
											Descrizione: Post-print non editoriale
										 
											Tipologia:
											2. Post-print / Author's Accepted Manuscript
										 
											Licenza:
											
											
												Pubblico - Tutti i diritti riservati
												
												
												
											
										 
										Dimensione
										4.46 MB
									 
										Formato
										Adobe PDF
									 | 4.46 MB | Adobe PDF | Visualizza/Apri | 
| Crovetti-A300mV.pdf accesso riservato 
											Tipologia:
											2a Post-print versione editoriale / Version of Record
										 
											Licenza:
											
											
												Non Pubblico - Accesso privato/ristretto
												
												
												
											
										 
										Dimensione
										5.81 MB
									 
										Formato
										Adobe PDF
									 | 5.81 MB | Adobe PDF | Visualizza/Apri Richiedi una copia | 
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11583/2909436
			
		
	
	
	
			      	